New Progress in Centralized Procurement of Chinese Herbal Pieces: 41 Varieties Included, 300 Billion Market Landscape to ChangeWallstreetcn·Apr 14 at 07:17 AM016660.00%00570+0.70%
In the "Performance" report, TONG REN TANG announced a full-year net profit of 396 million RMB, a decrease of 24.1%, with a final dividend of 18 centsAASTOCKS·Mar 29 at 12:21 AM016660.00%600085+0.15%
4 New stocks in the dark market "report success" with DeShi showing double profits, while HuaYan Robotics only rises by 10%Stheadline·Mar 27 at 08:26 PM03613-0.29%600085+0.15%
Tong Ren Tang healthcare unit pulls Hong Kong IPO scheduled for MondaySCMP·Mar 27 at 01:35 AM513700+0.35%016660.00%
Tongrentang Medical and Health has opened its IPO: plans to raise HKD 900 million and list on March 30, with a 10% decline in profits over 9 months雷帝触网·Mar 23 at 07:30 AM600085+0.15%03613-0.29%
TRT launches IPO to provide medical and health services relying on its time-honored brandBambooWorks·Mar 23 at 02:10 AM016660.00%600085+0.15%
【New Stock IPO】【Subscription Situation】【Continuously Updated】Traditional Chinese Medicine Healthcare Service Industry Tong Ren Tang Medical Care (2667) received HKD 250 million in margin financing, with an oversubscription of 1.8 timesTasty Money·Mar 22 at 09:54 PM600085+0.15%016660.00%
Tong Ren Tang Subsidiary Posts Lower 2025 Profit as Revenue and Margins DeclineTip Ranks·Mar 20 at 08:41 AM600085+0.15%03613-0.29%
Beijing Tong Ren Tang Chinese Medicine Sets HKD 0.37 Final Dividend for 2025Tip Ranks·Mar 20 at 08:10 AM600085+0.15%
Chinese Medicine Firm Seeks Elusive Elixir Of IPO Successbenzinga_article·Feb 5 at 01:11 PM016660.00%600085+0.15%
With only six months left until July 1, 2026, the implementation of Article 75 of the National Medical Products Administration's "Special Regulations on the Registration of Traditional Chinese Medicine" is entering its final window period. This regulation, referred to in the industry as the "death clause" for proprietary Chinese medicines, clearly states that after three years of implementation starting from July 1, 2023, the contraindications in the instructions will be prohibitedWallstreetcn·Jan 27 at 04:41 AM512290+0.60%159929+0.68%
